Indian Health Fund: 4 innovators selected for early detection of TB, malaria by Tata Trust and The Global Fund
Tata Trust and The Global Fund backed Indian Health Fund (IHF) has chosen four innovators for early detection of tuberculosis (TB), malaria to effectively tackle these eradicate diseases. Three selected innovators are related to TB and one to malaria. They were selected from proposals received for its second Request for Proposals.
The aim for selecting these innovators aims at leveraging technology for improving early detection and prompt treatment along with promoting diagnostics feasible for primary health care facilities. It also aims to supporting national efforts to effectively tackle eradicate these diseases which is crucial health challenges in India. Government has set a target of eliminating TB by 2025 and malaria by 2030. India contributes to 27% of the global TB burden and 68% of all malaria cases in the Southeast Asia region
Indian Health Fund (IHF)
IHF was launched in 2016 by Tata Trusts in collaboration with The Global Fund, to drive innovations towards key infectious disease challenges in India. It supports individuals and organisations with already germinated innovative strategies, services, products, such that they become sustainable and scalable solutions in addressing TB and malaria. The initiative is not a fellowship programme to do research from scratch. It is long-term exercise aligned with country’s goal of eliminating TB by 2025 and malaria by 2030. It will promote innovative solutions such that they are widely accessible and are affordable.